314930 — Biodyne Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Biodyne Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,454	-10,857	5,611	-992	10.8
Depreciation
Amortisation
Non-Cash Items	2,704	8,930	1,239	-1,034	-1,773
Unusual Items
Other Non-Cash Items
Changes in Working Capital	650	78.2	-5,822	765	1,018
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	116	-505	2,586	405	877
Capital Expenditures	-796	-866	-1,562	-670	-539
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	462	-14,499	205	-1,000	-5,372
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-334	-15,364	-1,357	-1,670	-5,911
Financing Cash Flow Items	—	-1,865	—	—	-193
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,806	22,109	-10.2	193	-204
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,325	6,471	1,280	-1,008	-4,893